Hepatitis B Virus Covalently Closed Circular DNA Predicts Postoperative Liver Cancer Metastasis Independent of Virological Suppression
New antiviral therapies against hepatitis B virus (HBV) focus on the elimination of covalently closed circular DNA (cccDNA). However, traditional cccDNA-specific quantitative PCR (qPCR) has a narrow effective range, hindering a reliable comparison between the levels of biopsy-derived cccDNAs. Collat...
Main Authors: | Chao-Wei Hsu, Yu-De Chu, Ming-Wei Lai, Chih-Lang Lin, Kung-Hao Liang, Yang-Hsiang Lin, Chau-Ting Yeh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/3/538 |
Similar Items
-
New Insights on Molecular Mechanism of Hepatitis B Virus Covalently Closed Circular DNA Formation
by: Alexander L. Marchetti, et al.
Published: (2020-11-01) -
Rapamycin inhibits hepatitis B virus covalently closed circular DNA transcription by enhancing the ubiquitination of HBx
by: Yuan Zhang, et al.
Published: (2022-08-01) -
CRISPR-Cas9 Targeting of Hepatitis B Virus Covalently Closed Circular DNA Generates Transcriptionally Active Episomal Variants
by: Maria Guadalupe Martinez, et al.
Published: (2022-04-01) -
Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance
by: Hung-Chih Yang, et al.
Published: (2014-01-01) -
Potential capacity of interferon-α to eliminate covalently closed circular DNA (cccDNA) in hepatocytes infected with hepatitis B virus
by: Gang Wang, et al.
Published: (2021-04-01)